Hailey P. Weerts

Development, Interlaboratory Evaluations, and Application of a Simple, High-Throughput Shigella Serum Bactericidal Assay

M. Nahm, M. Pasetti, Sachin Mani, 2018, mSphere.

Immunization of Rabbits with a Quadrivalent Shigella Bioconjugate Vaccine Induces Functional Antibodies Reactive with Shigella Isolates from Kenya

Lillian Musila, E. Odundo, L. Ogonda, 2022, mSphere.

Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G

R. Frenck, M. Venkatesan, A. L. Bourgeois, 2020, mSphere.

Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G

R. Frenck, M. Venkatesan, A. L. Bourgeois, 2020 .

A High-throughput Shigella-specific Bactericidal Assay.

M. Nahm, Jigui Yu, R. Kaminski, 2019, Journal of visualized experiments : JoVE.

Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccine

D. Sack, S. Chakraborty, A. L. Bourgeois, 2021, EBioMedicine.

Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection

D. Sack, S. Chakraborty, A. L. Bourgeois, 2021, EBioMedicine.

GMP manufacture of Shigella flexneri 2a Artificial Invaplex (InvaplexAR) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteers.

M. Riddle, C. Porter, E. Oaks, 2023, Vaccine.